Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05777265
Other study ID # CBU-FTR-ES-O2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2023
Est. completion date July 15, 2023

Study information

Verified date August 2023
Source Celal Bayar University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the effects of 16-week CT on physical fitness parameters, pulmonary function, and quality of life in healthy women.


Description:

Circuit training (CT) is an important type of training that can combine different types of exercises in a single form of training. This training is generally circular with the different exercise stations it contains, so it is known as CT. The initial protocol of this training, developed by researchers at the University of Leeds in 1953, consisted of 9 to 12 moderate intensity exercises (40% to 60% of 1RM) performed at different exercise stations and with a specific repetition and duration. Nowadays, it is seen that this training is applied in different intensities and protocols. Also, CT has gained popularity due to its practicality and effectiveness and is preferred by all age groups in recent years. CT can be applied in many sport settings and does not require expensive equipment. Also, this training can be adjusted to any level of physical fitness and includes bodyweight exercises and functional movements. This training generally includes aerobic and strengthening exercises and improves musculoskeletal, cardiovascular and pulmonary functions. On the other hand, CT allows individual interaction both between participants and between participants and the sports or health professionals who provide this training. Lastly, the hallmark of CT is that it includes different exercise stations and short rest periods without breaks and the advantage of CT is that it effectively improves several parameters of physical fitness simultaneously. Current literature investigating the effects of CT on physical fitness parameters in different populations is still emerging. However, it was seen that few studies focused on the healthy women population. Also, it was concluded that these studies reported different results regarding the effects of CT. Accordingly, it has been concluded that 6-week CT improved lower and upper extremity muscle strength and endurance, but had no positive effect on flexibility and body composition in healthy women. However, it has been reported that 12-week CT had no positive effect on body composition, knee flexor and extensor muscle strength in healthy women. Lastly, it has been concluded that12-week of CT had positive effects on body composition, and improved flexibility and lower extremity muscle strength in healthy women. These results in the literature suggested there is no clear consensus on the effects of CT on physical fitness parameters in healthy women. Moreover, the fact that CT also includes aerobic exercises shows this training may also have an effect on pulmonary function. In this context, previous studies reported the positive effects of this training on pulmonary function in adolescent, professional volleyball players, women with sarcopenia, and people with human immunodeficiency virus. However, there is insufficient evidence regarding the effects of CT on pulmonary function in healthy women. To the best of our knowledge, only one previous study reported the positive effects of CT on some pulmonary function in healthy women. Accordingly, it is clear that studies is needed to examine the effects of CT on pulmonary function on healthy women. This training may also improve pulmonary function in healthy women by increasing the performance of the diaphragm muscle through aerobic exercise. Moreover, these positive effects on pulmonary function may also improve quality of life in healthy women. Lastly, similar to physical fitness parameters, studies investigating the effects of CT on quality of life also included different populations. However, it was concluded there were few studies that included healthy women and the results of these studies differed. Therefore, the aim of this study is to investigate the effects of 16-week CT on physical fitness parameters, pulmonary function, and quality of life in healthy women. Also, the investigators hypothesized that the 16-week CT would be positive effects on physical fitness parameters, pulmonary function, and quality of life in healthy women.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date July 15, 2023
Est. primary completion date July 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - volunteering to participate in study - not have any musculoskeletal disease Exclusion Criteria: - history of malignancy - using any drugs or supplement - history of any surgery - being pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Circuit Training
CT will be applied to the participants, taking into account the recommendations of the American College of Sports Medicine (ACSM), 3 days a week, an average of 40 minutes a day, for a total of 16 weeks. Warm-up and cool-down protocols will be applied before and after each CT, and each exercise will be performed as 15 repetitions and an average of 40 seconds of rest will be given between exercises. Also, the intensity of CT will be determined according to the Borg scale (between 11 and 14). CT will include 'mini squat', 'step up', 'sit ups', 'reverse sit ups', 'leg press', 'leg curl', 'leg extension', 'crunches', 'lunge', 'prone bridge', and 'side bridge' exercises.

Locations

Country Name City State
Turkey Izmir Katip Celebi University Izmir

Sponsors (1)

Lead Sponsor Collaborator
Celal Bayar University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body Mass Index (kg/m2) Body Mass Index (kg/m2) will be assessed with the Bioelectrical Impedance Analysis System. Sixteen week
Primary Waist(cm)/Hip(cm) Ratio (%) Waist(cm)/Hip(cm) Ratio (%) will be assessed with the Bioelectrical Impedance Analysis System. Sixteen week
Primary Muscle Strength Muscle strength will be assessed with the isokinetic dynamometer Biodex System-4 Pro (Biodex, Shirley, New York), which is a valid and reliable method. The strength of right/left knee flexor, and extensor muscles of the participants will be determined by mean peak torque at '60°/sec and 180°/sec angular velocities. Sixteen week
Primary Flexibility Flexibility will be assessed with the sit-and-reach test, which is a valid, and reliable method. Participants will be asked to reach forward as far as possible three times without bending their knees after one trial. The obtained values (cm) will be recorded and the best value will be used for analysis. Sixteen week
Secondary Forced Expiratory Volume in 1 Second (FEV1) (L/sec) Forced Expiratory Volume in 1 Second (FEV1) (L/sec) will be assessed with a spirometer (Minispir, Italy) device. Measurement will be taken with the participant seated and in the resting state. Primarily the nose latch will be fitted to prevent air leakage. Then, the participant will be asked to inhale as much as possible and then exhale as quickly and completely as possible. This process will be repeated 3 times, and the highest values will be used for analysis. Sixteen week
Secondary Forced Vital Capasity (FVC) (L) Forced Vital Capasity (FVC) (L) will be assessed with a spirometer (Minispir, Italy) device. Measurement will be taken with the participant seated and in the resting state. Primarily the nose latch will be fitted to prevent air leakage. Then, the participant will be asked to inhale as much as possible and then exhale as quickly and completely as possible. This process will be repeated 3 times, and the highest values will be used for analysis. Sixteen week
Secondary FEV1/FVC (%) FEV1/FVC (%) will be assessed with a spirometer (Minispir, Italy) device. Measurement will be taken with the participant seated and in the resting state. Primarily the nose latch will be fitted to prevent air leakage. Then, the participant will be asked to inhale as much as possible and then exhale as quickly and completely as possible. This process will be repeated 3 times, and the highest values will be used for analysis. Sixteen week
Secondary Peak Expiratory Flow (PEF) (L/min) Peak Expiratory Flow (PEF) (L/min) will be assessed with a spirometer (Minispir, Italy) device. Measurement will be taken with the participant seated and in the resting state. Primarily the nose latch will be fitted to prevent air leakage. Then, the participant will be asked to inhale as much as possible and then exhale as quickly and completely as possible. This process will be repeated 3 times, and the highest values will be used for analysis. Sixteen week
Secondary Life Quality Quality of life will be assessed with the Short Form-36 (SF-36), a valid and reliable scale developed by Ware et al. It includes mainly the physical and the mental function scores. The best score is "100" and the worst score is "0". Higher scores indicate better physical or mental functioning. The obtained physical and the mental function scores will be used for analysis. sixteen week
See also
  Status Clinical Trial Phase
Completed NCT02575209 - Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects N/A
Active, not recruiting NCT03124160 - Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard Phase 3
Completed NCT01879891 - Exercise Intensity, Metabolic Rate and Insulin Sensitivity N/A
Not yet recruiting NCT06395064 - The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy: Randomized-controlled Trial N/A
Completed NCT02720783 - Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary Phase 1
Recruiting NCT04143659 - A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception Phase 1
Completed NCT01764412 - Study of Serum Hepcidin Rate Variations During Menstrual Cycle N/A
Completed NCT05777252 - Effects of 16-Week Circuit Training in Healthy Women N/A
Completed NCT03147703 - Timing of Food Intake Impacts Daily Rhythms of Human Saliva Microbiota N/A
Recruiting NCT05994599 - Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring Phase 1
Not yet recruiting NCT03961412 - A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women Early Phase 1
Completed NCT02908503 - Vaginal Film Administration and Placement Study: FLAG N/A
Completed NCT01293591 - Garlic Intake And Biomarkers Of Cancer Risk N/A
Completed NCT02268032 - Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve Phase 1
Completed NCT02994602 - Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males Phase 1
Completed NCT04189796 - Jarlsberg Cheese Compared to Camembert Cheese N/A
Recruiting NCT03432416 - Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring Phase 2
Unknown status NCT01809405 - Validation of Sexual Function Scale in Female Cancer N/A
Completed NCT03412617 - Diets, Metabolic Profile and Gut Microbiota Among Indonesian Women in Minangkabau and Sundanese-ethnic Community N/A
Completed NCT02112903 - Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women Phase 1